Clark Dental has launched the new Nomad Handheld X-Ray machine from Aribex™.
According to the company, Nomad already has a superb track record as a practical, effective and recognised state-of-the-art device. It boasts a multitude of benefits and features and is suitable for many different environments. Two rechargeable batteries provide 150 exposures each, and it’s compatible with both digital sensors and traditional X-ray film.
The operator is protected by a patented internal radiation shield as well as an external backscatter shield, which the company says provides excellent protection: one operator would have to expose over 10,000 E-speed films per year in order to approach the lowest measurable dose on a monitoring badge. With a direct digital sensor, the scatter dose is even less.
For further information, please contact the exclusive UK supplier, Clark Dental, on Tel: 01270 613750 or email maria@clarkdental.co.uk
Virbac has launched Cooldent, described as a highly palatable, fast-acting tablet to freshen dogs' breath.
Claire Lewis, Product Manager, explained: "Bad breath in dogs is unpleasant and is most frequently caused by a build-up of plaque and calculus on their teeth.
"Cooldent's natural ingredients have an anti-plaque action and help both to maintain a balanced intestinal flora and to reduce gas production. They also help to freshen dogs’ mouths by contributing to the reduction of volatile compounds, produced by bacteria which can cause halitosis."
She added: "We are delighted to add Cooldent to our comprehensive dental range, alongside our VeggieDent, natural, all-vegetable, highly palatable teeth-cleaning chews for dogs and Vet Aquadent, an easy-to-use drinking water additive which helps to fight dental plaque and tartar formation in dogs and cats."
The Department for Environment, Food and Rural Affairs (Defra) has today released details of the strategy for rolling out vaccination across England.
Under EU law, vaccination can only be carried out in a Protection Zone. As vaccine starts to be delivered by Intervet, vaccination will, therefore, commence in the Protection Zone only. Once vaccination is progressing across the Protection Zone, the intention is to extend or modify the Zone county by county, in order to permit further vaccination. The strategy has been developed and agreed with a Core Group of industry stakeholders. It is designed to be flexible, taking into account the changing nature of the disease, such as moving zones, the varying levels of disease risk in the zones and the availability of vaccine.
More details of the vaccination strategy, alongside indicative prices for the vaccine, can be found on the Defra website: http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/control/vaccination-rolloutplan.htm
The Royal College of Veterinary Surgeons Council and the Veterinary Nursing Council have decided that there will be no increase in registration and retention fees for veterinary surgeons and veterinary nurses for 2012.
Last year, the Councils decided that a lower than inflation increase should apply to fees for 2011 to help mitigate the impact of the difficult economic climate on veterinary surgeons and veterinary nurses. Members who are over 70 and who cease practising do not have to pay fees if they wish to remain on the Register.
Bradley Viner, RCVS Treasurer said: "We know times are tough financially for many people and hope that freezing fees will help a little. Professional regulation can be costly, but we try to keep fees as low as possible."
The RCVS financial policy remains that fee increases should be small and incremental in order to avoid a need for periodic sharp fee hikes resulting from inflationary pressures.
Fees for 2012 will be as follows:
2012 fees (£)
Veterinary surgeons
UK-practising retention fee
299
Overseas-practising retention fee
150
Non-practising retention fee
49
Non-practising retention fee (over 70 years old)
0
Registration fee
Temporary registration fee
Restoration fee
Restoration fee following voluntary removal
75
Veterinary nurses
Retention fee
61
The March 2025 Cattle Highlights Report from the Royal GD in the Netherlands has revealed that the proportion of paromomycin-resistant isolates has jumped from 48% in 2021 to 72% in 2024.
The report also highlights an increase in the detection of cryptosporidiosis in calves up to 14 days of age.
MSD says that while it is unclear whether paromomycin is being used to treat E.coli or cryptosporidiosis, the rising use of the antibiotic could be contributing to greater exposure and increased resistance in E.coli K99.
Kat Baxter-Smith MRCVS (pictured), a vet advisor at MSD Animal Health, said: “What we need now is a mindset shift—moving away from routine antibiotic use and towards a more robust, preventative management strategy.
“It’s not about eliminating treatment altogether but using it only when it is really needed.”
“Vaccination, clean pens, and ensuring that every calf receives the right volume and quality of colostrum are the real cornerstones of effective scour control.
“Using vaccines such as Bovilis Rotavec Corona for rotavirus, coronavirus, and E.coli and Bovilis Cryptium for Cryptosporidium parvum is one of the most effective ways to reduce the incidence of neonatal diarrhoea.
"By vaccinating the dam, we ensure the calf has the best possible immunity at birth by ingesting the fortified colostrum and transition milk in the first days of life, which significantly reduces reliance on antibiotics and minimises disease risks.”
The report emphasises best-practice principles such as effective colostrum management, good hygiene and housing, balanced dry cow transition and strategic vaccination of the dam.
The report also recommends halofuginone (Halocur) as the first-line treatment for cryptosporidiosis, due to its targeted action and significantly lower risk of contributing to AMR.
Kat added: "By embracing these proactive strategies, vets and farmers can take a crucial step towards safeguarding calf health, reducing reliance on antibiotics, and combating the growing threat of antimicrobial resistance.”
https://issuu.com/gezondheidsdienstvoordieren/docs/highlights_report_cattle-march_2025
The RCVS has announced that nominations are now open for the RCVS Elections and launched a new video which explains why you should consider putting your name forward.
Six seats are available on RCVS Council, each for a four-year tenure. Existing RCVS Council Members David Catlow, Jacqui Molyneux, Bob Partridge, Christine Shield, Neil Smith and Clare Tapsfield-Wright are due to retire from Council next year, but are all eligible for re-election.
Last year, for the first time in over a decade, no women candidates stood for election, and the College says it is determined to widen participation in Council amongst the whole profession.
To help veterinary surgeons learn more about what's involved in being a Council Member, the benefits it can bring and the amount of time it requires, the College has produced a short video featuring the experiences of some existing members of Council and their reasons for standing.
Gordon Hockey, RCVS Registrar, said: "We have chosen the theme 'People like you' for these videos because people on the Councils really are no different to their colleagues across all aspects of the veterinary and veterinary nursing professions. The thoughts and experiences they describe on camera will sound very familiar to many of their colleagues and peers! We need people of all ages and of varying experiences and professional backgrounds to ensure there is a healthy and diverse range of views available."
The College will also be hosting a special 'Meet the RCVS' day on Tuesday, 10 December for anyone considering standing for election but wanting to find out more first. Further information and bookings are available from Fiona Harcourt, Communications Officer (020 7202 0773 / f.harcourt@rcvs.org.uk).
Nominations are open until 5pm on Friday, 31 January 2014, allowing plenty of time to find out more about what's involved and to find two proposers.
Details about how to stand in the elections are available at www.rcvs.org.uk/rcvscouncil14.
Hill’s Pet Nutrition has launched Prescription Diet Feline c/d Multicare, formulated to manage both struvite and oxalate urinary stones. It's appropriate for cats with feline idiopathic cystitis, which accounts for an estimated 64% of all FLUTD cases. The new diet replaces x/d, which will be discontinued.
According to Hill's, a significant benefit is that c/d contains no excess salt and therefore presents no risk to cats that have hidden kidney disease. Libby Sheridan, Veterinary Affairs Manager, said: “It’s something that is always at the back of our minds when cats have shown signs of urinary tract problems: has there been damage to the kidneys that I can’t yet detect? We need to be cautious when it comes to managing urinary disease in cats. Limiting salt with careful diet formulation and therefore avoiding potentially worsening compromised kidneys is important in long term management.”
Feline c/d Multicare contains controlled levels of magnesium, calcium, phosphorus and oxalate to reduce the constituents of crystals and calculi, added citrate to reduce stone formation and enhanced levels of B6 specifically to decrease the risk of oxalate formation. Increases in omega-3 fatty acids help ensure that the inflammatory response is ameliorated, which is particularly important in the management of feline idiopathic cystitis.
Hills continue to recommend s/d for dissolution of struvite calculi and k/d in cases of feline urate calculi. Feline urinary disease is, of course, a condition that requires long term intervention to guard against recurrence and c/d Multicare is available in a variety of flavours and formats, including tender chunks in gravy pouches, 156 g tins and dry in chicken and ocean fish varieties, ensuring there is a enough choice to satisfy the most discerning of cats.
For more information call Hill’s Customer Service on 0800 282 438 or (ROI) 1-800 626002.
Dr Sarah Caney, RCVS specialist in feline medicine has launched http://www.catprofessional.com/, a new website for vets and nurses that want to become more feline friendly, and those in the animal health industry who want to be cleverer in their approach to cats.
The new site, which has been developed by Dr Caney’s own company Cat Professional Ltd, offers articles for vets and owners on various aspects of cat care, as well as detailing upcoming events and publications.
In addition, companies can access a range of consultancy services, including assistance with clinical trials and product design.
There is a facility to book training sessions and lecture slots at home and abroad with Dr Caney, who is a renowned speaker, able to combine her expertise in feline medicine with a gift for communicating difficult concepts in a way that makes learning an enjoyable experience.
Dr Caney’s latest book, ‘Caring for a Cat with Kidney Failure’ is available as an environmentally friendly download or to purchase as a hard copy from the site. Aimed at vets and cat owners, the book includes step-by-step instructions on how to give medication and better cater for a cat’s needs, providing another tool that will help owner compliance and therefore quality of life in renal failure cats.
For vets, nurses and other cat professionals, perhaps the biggest bonus is that the site provides a direct line of communication to Dr Caney and access to her vast knowledge of all things feline: from effective handling techniques to the best therapeutic protocols.
Two equine journals have joined forces to create a free online collection of their recent articles on endocrinology to raise awareness of these common disorders and to provide veterinary surgeons with what they say is a definitive source of references all in one place.
The collection of references published by Equine Veterinary Education (EVE) and Equine Veterinary Journal (EVJ) covers a range of topics within the field of endocrinology and includes authoritative review articles on insulin dysregulation2, glucocorticoids and laminitis3 and paraneoplastic syndromes4.
The initiative has been made possible with the support of British Equine Veterinary Association Trust and has been compiled by leading international authorities on equine endocrinology, Professor Philip Johnson, of University of Missouri and Professor Nicholas Frank of Tufts University, Boston and the University of Nottingham.
They say that equine endocrine disorders, such as Pituitary pars intermedia dysfunction (PPID), are becoming more promptly identified and treated, thanks to ongoing research and advances in diagnosis, pharmacokinetics and management protocols.
PPID, or Cushing's, is a progressive neurodegenerative condition that is more easily recognised in its advanced form in older horses. Surveys show a PPID prevalence rate of up to 22% in horses over the age of 155, with the odds of developing clinical signs associated with PPID increasing by approximately 20% per year after this age.
Insulin dysregulation (ID), characterised by increased insulin response to oral sugars, hyperinsulinaemia and insulin resistance, is identified in both PPID and equine metabolic syndrome (EMS)2. Both PPID and EMS have been linked to the development of recurrent laminitis with subsequent high risk of mortality6. The exact mechanisms which link insulin to laminitis remain to be clarified1 but this online collection highlights several studies, which partially address this important jigsaw7-12.
Best practice for the management of EMS is outlined by Professors Nick Frank and Ray Geor in the December issue of EVE13. The first goal is to induce weight loss, and guidelines for designing diets for obese equids are provided. Exercise and dietary management14 have been shown to reduce the clinical signs and indices of inflammation in equine metabolic syndrome13 - 15, however, further studies are needed to quantify the efficacy of these management changes on long-term outcomes.
The online collection also includes several studies addressing the diagnosis of PPID. The value of plasma adrenocorticotropin hormone (ACTH), when interpreted with seasonally adjusted reference ranges, is discussed by several authors18-20. Professors Frank and Geor advocate it as the most readily accessible test for monitoring PPID cases in a field setting, although they maintain that the thyrotropin- releasing hormone (TRH) stimulation test is more sensitive and therefore has advantages when diagnosing PPID in its early stages13.
Pergolide has emerged as the drug of first choice for treatment of PPID13. While many vets recommend the early introduction of medication in the hope that it may avert the specter of laminitis, at present, there are no trials comparing pergolide with alternatives. Furthermore, there have been no long-term studies to show that horses treated with pergolide before the onset of clinical signs of PPID have better outcomes, including a reduced incidence of developing laminitis, than horses in which treatment is delayed until clinical signs become apparent.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "Better control of PPID and insulin dysregulation should lower the risk of laminitis to help improve the health and longevity of many predisposed horses and ponies.
"Raising awareness of the benefits of early diagnosis and sharing the latest research on these and other associated conditions are imperative to provide horse owners with the best diagnostic and treatment programmes for their horses. However, it is easy to under-estimate obesity: horse owners need to think about improving management of their horses' feeding and exercise in order to avert problems before they become a veterinary issue."
References
The International Elbow Working Group has announced a pre-congress meeting at WSAVA in August. The meeting is sponsored by Hills Pet Nutrition and is being held on Wednesday 20th August at University College Dublin.The meeting offers the opportunity to hear some of the most influential researchers in the field.The speakers include Professors Hazewinkel and Hedhammar who were responsible for the seminal work that identified that high calcium high energy diets could increase the propensity to developmental bone disease. Professor Hedhammar will be delivering a presentation on the genetics of elbow dysplasia and the implications for breeding programmes, while Professor Hazewinkel will be discussing diagnosis. Representing the UK, Dr Noel Fitzpatrick will discuss the decision making algorithm for conservative and surgical treatment of elbow dysplasia, incorporating the latest thinking on how to manage the disease. Other topics being presented on the day will be imaging techniques by Professor Van Bree and grading of osteoarthritic lesions by Dr. Tellhelm.The group has invited practitioners and researchers to submit posters and free communications on the topic of elbow dysplasia for presentation up until 20th July. The congress fee is 80 euros which includes lunch and refreshments. Further details and a registration form can be downloaded at www.iewg-vet.org.
The materials include pet owner guides, reception posters and slides to display on waiting room TV.
They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.
Renzo Di Florio, Krka’s Technical Veterinary Adviser said: “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.
"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.
"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”
https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs
Unlike traditional PCR tests, Rhea molecular diagnostic tests need no lab equipment, allowing them to be used directly in the field.
The first panel test in the new range is Rhéa Vector-Borne Diseases, which simultaneously detects four major pathogens in under 40 minutes: Theileria spp., Babesia spp., Anaplasma spp. (including A. marginale and A. phagocytophilum), and Borrelia spp.
Enalees says the Rhéa range addresses a growing need in the sector, enabling vets to act quickly and accurately.
https://www.enalees.com
The company says farmers should be vaccinating their flocks to help protect the cohort of ewes that missed last year’s vaccination.
Flock replacements should also be vaccinated this summer ahead of tupping.
Shearlings (one year plus) and older can be vaccinated with Cevac Chlamydia within four months before tupping and no later than four weeks before the rams go in, while ewe lambs can be vaccinated from five months of age.
The vaccine should not be used in pregnant ewes.
Fiona Lovatt BVSc PhD FHEA DSHP DipECSRHM FRCVS from Flock Health Ltd said: “It is really good news to hear that there will be good availability of EAE vaccine this year.
"The lambing season started off with some disappointing news for some farmers who were not able to vaccinate last year as they faced EAE abortions.
"We are emphasising to these farmers and others that it is essential that the youngest two years of the ewes are vaccinated before next tupping to ensure that the cohort that missed last year’s vaccination are fully covered.”
https://ruminants.ceva.co.uk.
Pete Wedderburn MRCVS is reporting on the latest veterinary developments in the USA, with a daily blog from the Western Veterinary Conference in Las Vegas.
You can read / subscribe to Pete's engaging blog here.
They include a webinar from In Communication, a company which specialises in veterinary client communications, which covers things like how to broach costs with clients, communicating treatment options succinctly and time-blind shared decision-making.
The Society has also published eight questions which the public may ask about the investigation, with model responses.
The resources also include a summary of the five concerns raised by the CMA, and advice about how to discuss them with practice staff.
Finally, you can download SPVS' presentation to the CMA which talks about the drivers for fee increases.
https://spvs.org.uk/cma-spvs-response
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations close on 30th October 2024 and the winners will be announced on 16th January 2025.
The BSAVA awards ceremony will take place at the reinvented Congress and Expo 2025, taking place at Manchester Central in March.
https://www.bsava.com/awards.
The Bella Moss Foundation and the Royal Society of Medicine have announced 'One Health', a conference which will bring together experts from the veterinary and medical sectors to collaborate on infectious disease.
Subjects under discussion will include infection control, antimicrobial resistance and the threats posed by emerging zoonotic diseases. Amongst the speakers will be Professor Peter Borriello, Chief Executive of the Veterinary Medicines Directorate and Professor Anthony Kessel, Director of Public Health England. The audience will include policy makers and clinicians together with researchers and academics from both human and veterinary medicine.
Jill Moss, President of the Bella Moss Foundation, said: "With antimicrobial resistance and updated protocols hitting the headlines regularly, our speakers will discuss the key issues. For instance, what exactly is the current status of antimicrobial resistance? How is it affecting our lives? What are the veterinary, medical and research professions doing to resolve the challenges we face - and how can they persuade policy makers to take a united stand on the issue?"
Tom Keith - Welsh president of comparative medicine network, Royal Society of Medicine, said: "Antimicrobial resistance is a global issue requiring education, information and action. The conference programme will provide anyone with an interest in antimicrobial resistance a current and rounded perspective on this important and pressing issue."
For more information, visit: www.onehealthbmf.com.
Biomérieux says the new test, which is used on the Biofire Spotfire System, detects seven infectious respiratory pathogens (six viruses and/or a strain of bacteria*), from a nasopharyngeal swab, in under 20 minutes.
The company says the new test’s ability to distinguish between viral and bacterial infections is important for ensuring antibiotics are used appropriately to reduce the risk of resistance.
Biomérieux says VetFire can be used to make informed decisions about when to isolate and treat animals when respiratory infections are suspected, to mitigate the impact of an outbreak in a contained area, such as a yard, by allowing rapid quarantine measures, and perhaps in time as a standard test ahead of animals travelling for competition, to ensure they are fit and healthy.
VetFire is commercially available in United Kingdom, Ireland and France, with possible expansion plans to other countries in the near future.
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vetfire.html
*Equine Herpesvirus type 1, Equine Herpesvirus type 4, Influenza A, Equine Rhinovirus A, Equine Rhinovirus B, Equine Adenovirus 1, Streptococcus equi equi
The modules are 20 minutes long each.
The first: "The Key Components of Successful Anaesthesia", covers the basics of companion animal anaesthesia and analgesia.
The second module: "The Benefits of Zoletil", looks at Zoletil as an anaesthetic and explains the advantages it offers.
Licensed for cats and dogs, Zoletil comprises a coactive balance between Tiletamine & Zolazepam.
Virbac says it is ideal for short and medium duration anaesthesia with multiple administration routes including IV or IM administration, making it a versatile choice of anaesthetic.
https://vet-uk.virbac.com/home/products/dogs/anaesthetics--analgesics/zoletil-100.html
The webinars cover a range of clinical topics, including evaluating Brachycephalic Obstructive Airway Syndrome (BOAS), cognitive decline in senior dogs, cannabinoid therapy, feline weight loss, corneal ulcers and seizure management.
Vet and Tech says the 10-session series features speakers from top veterinary institutions.
The webinars are available both both live and on-demand.
https://www.vetandtech.com/webinars
The updated content includes instructions on interpreting blood test results and dosing with Felimazole (thiamazole), which is now available as both a tablet and a honey-flavoured oral solution.
The new Felimazole Oral Solution formulation is presented in a syringe graduated in 0.25 mg increments to ensure accurate dosing.
Thomas Johnson, Dechra companion animal brand manager said: “Consistent management and accurate treatment is key to enabling cats with feline hyperthyroidism to lead long and healthy lives.”
Dechra’s Endocrine app already covers Addison’s disease and canine Cushing’s syndrome. The inclusion of feline hyperthyroidism content aims to provide a single resource for veterinarians managing endocrine disorders in companion animals.
Dechra’s Endocrine app is available at the Apple App Store or Google Play Store
https://www.dechra.co.uk/products#/search=Felimazole
BraveBites contains protein, fish oil (rich in omega-3) and prebiotics.
The snack, which was developed with a veterinary nutritionist, has a soft texture and high palatability.
Camille, who worked for a year at Fitzpatrick Referrals, said: “In dogs undergoing cancer treatment, decreased appetite and weight loss are common.
"They negatively affect both prognosis and quality of life.
“Owners were constantly asking what they could still give their dog when food refusal started.”
Camille says that in a field test across 40 veterinary clinics in Belgium and the Netherlands, over 95% of oncology patients accepted the snack well, with a reported improvement in appetite and quality of life
BraveBites is available direct to vets, with educational material, client brochures, and quality-of-life monitoring tools.
http://www.bravebitespetfood.com
Stephen was recognised for his services to veterinary education and animals in science.
He served as RCVS President from 2017 to 2018 and has been actively involved in the work of the College for many years, serving a total of 19 years as a Council member, both as a vet school-appointee and an elected member, before retiring in 2024.
During his time on Council, he led the Legislative Reform Working Group which developed the Legislative Reform Proposals, as well as the Graduate Outcomes Project, out of which the Veterinary Graduate Development Programme was developed.
Kulin was recognised for his services to animal health and international trade.
RCVS President, Linda Belton MRCVS, said: “Huge congratulations to both Professor May and Dr Patel on this outstanding achievement.
"Thank you both for your extraordinary contributions to the veterinary profession during your careers, for which I would like to extend my appreciation on behalf of everyone at the RCVS.
“I would also like to extend congratulations to all those mentioned in the King’s Birthday Honours List for contributions to the veterinary world, animal health and welfare, and to the One Health concept more generally.
"We could not do the work we do without vital stakeholder collaboration, and it is fantastic to see outstanding individuals in the field being recognised for all they have contributed to our society.”